A rare complication in a child undergoing chemotherapy for acute lymphoblastic leukemia: superior sagittal sinus

Ting-Yao Wang1, Hsiu-Ju Yen, Giun-Yi Hung

  • 1Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.

Insights

A rare thrombotic complication, superior sagittal sinus thrombosis, occurred in a child undergoing acute lymphoblastic leukemia chemotherapy. Prompt treatment with low-molecular weight heparin (LMWH) led to neurological recovery and allowed chemotherapy continuation.

Area of Science:

  • Pediatric Oncology
  • Neurology
  • Hematology

Background:

  • Acute lymphoblastic leukemia (ALL) treatment involves intensive chemotherapy regimens.
  • High-risk ALL patients may experience severe complications during treatment.
  • Chemotherapy agents, including corticosteroids and l-asparaginase, can induce hypercoagulable states.

Observation:

  • A 4-year-old boy with high-risk ALL developed generalized tonic-clonic seizures and status epilepticus during reinduction chemotherapy.
  • Brain MRI revealed superior sagittal sinus and cerebral venous thrombosis.
  • The patient presented with left hemiparesis following the thrombotic event.

Findings:

  • Treatment with low-molecular weight heparin (LMWH) rapidly improved left hemiparesis within 1 week.
  • The patient achieved full ambulation 3 weeks after LMWH initiation.
  • Subsequent chemotherapy cycles were completed without complications under LMWH therapy.

Implications:

  • This case highlights the significant correlation between l-asparaginase/corticosteroid combination therapy and superior sagittal sinus thrombosis (SST) in pediatric ALL.
  • Early recognition and prompt anticoagulation with LMWH are crucial for managing SST and preventing long-term neurological sequelae.
  • Vigilant monitoring for thrombotic events in pediatric cancer patients receiving specific chemotherapeutic agents is essential.